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Abstract
Lipin 1 is a bifunctional protein that serves as a metabolic enzyme in the triglyceride synthesis pathway and regulates gene
expression through direct protein-protein interactions with DNA-bound transcription factors in liver. Herein, we
demonstrate that lipin 1 is a target gene of the hepatocyte nuclear factor 4a (HNF4a), which induces lipin 1 gene
expression in cooperation with peroxisome proliferator-activated receptor c coactivator-1a (PGC-1a) through a nuclear
receptor response element in the first intron of the lipin 1 gene. The results of a series of gain-of-function and loss-of-
function studies demonstrate that lipin 1 coactivates HNF4a to activate the expression of a variety of genes encoding
enzymes involved in fatty acid catabolism. In contrast, lipin 1 reduces the ability of HNF4a to induce the expression of genes
encoding apoproteins A4 and C3. Although the ability of lipin to diminish HNF4a activity on these promoters required a
direct physical interaction between the two proteins, lipin 1 did not occupy the promoters of the repressed genes and
enhances the intrinsic activity of HNF4a in a promoter-independent context. Thus, the induction of lipin 1 by HNF4a may
serve as a mechanism to affect promoter selection to direct HNF4a to promoters of genes encoding fatty acid oxidation
enzymes.
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Introduction
The control of hepatic intermediary metabolism is critical to
maintaining systemic energy homeostasis. For example, during
conditions of nutrient scarcity (fasting), the liver takes up and
oxidizes fatty acids to provide the brain and other peripheral
tissues with ketone bodies and uses the chemical energy stored in
fat to drive gluconeogenesis. The liver also provides lipid to other
peripheral tissues by esterifying fatty acids into triglycerides (TG)
and secreting them in the form of very low density lipoproteins
(VLDL). Complex regulatory mechanisms have evolved to control
hepatic fatty acid utilization, trafficking, and export. However,
nutrient excess and obesity perturb the ability of the liver to
maintain homeostasis and these hepatic metabolic abnormalities
contribute to the hyperglycemia and dyslipidemia that are
prevalent in type 2 diabetes mellitus.
Recent work has demonstrated that the lipin family of proteins
(lipin 1, 2, and 3) are critical regulators of hepatic intermediary
metabolism [1] that are strongly affected by alterations in energy
homeostasis [2,3]. Lipins are bifunctional intracellular proteins
that regulate fatty acid metabolism at two distinct regulatory levels.
Lipins act as phosphatidic acid phosphohydrolase (PAP) enzymes
that catalyze the dephosphorylation of phosphatidic acid (PA) to
generate diacylglycerol (DAG); the penultimate step in triglyceride
(TG) synthesis [4,5,6]. Unlike other enzymes in the TG synthetic
pathway that are integral membrane proteins, lipins are soluble
and contain a nuclear localization signal [7,8,9]. Lipins also act as
transcriptional regulatory proteins by associating with DNA-
bound transcription factors to modulate their activity [7,10,11]. In
liver, lipin 1 interacts with and coactivates the peroxisome
proliferator-activated receptor a (PPARa) and its coactivator
(PPARc coactivator 1a (PGC-1a)) to enhance the expression of
genes involved in fatty acid oxidation by recruiting in other
coactivator proteins with histone acetyltransferase activity [10].
The effects of lipin 1 on hepatic fatty acid oxidation can proceed
independent of PPARa, but not PGC-1a [10], suggesting that
other transcription factor partners of PGC-1a are also involved in
this response.
Hepatic lipin 1 expression is robustly induced in liver by food
deprivation in a PGC-1a-dependent manner [10]. The induction
of lipin 1 by fasting likely serves to enhance fatty acid catabolism
under fasting conditions since knockdown of lipin 1 by shRNA
markedly attenuates the fasting-induced increase in the expression
of fatty acid oxidation enzymes. Conversely, forced lipin 1
overexpression increases the expression of these enzymes and
stimulates hepatic ketone production [10]. Mice with a genetic
defect in lipin 1 (fatty liver dystrophic (fld) mice) exhibit a severe
hepatic steatosis characterized by marked reductions in the
expression of fatty acid oxidation enzymes [10]. Thus, lipin 1
appears to be a critical regulator of hepatic fatty acid utilization.
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While it is clear that lipin 1 is a direct target gene of PGC-1a,
the other components of the transcriptional complex that
cooperate with PGC-1a to regulate lipin 1 expression remain
unclear. Herein, we demonstrate that PGC-1a works with the
hepatocyte nuclear factor 4a (HNF4a) to regulate of lipin 1
expression in liver cells. We also show that the induction of lipin 1
feeds forward to modulate HNF4a activity in a promoter-specific
manner to direct this nuclear receptor to activate hepatic fatty acid
oxidation while suppressing expression of genes encoding apopro-
teins. These data further elucidate the regulatory mechanisms by
which lipin 1 controls hepatic metabolism and suggest that the
transcriptional regulatory function of this protein serves to fine-
tune hepatic metabolic control.
Methods
Mouse Studies
All animal experiments were approved by the Animal Studies
Committee of Washington University School of Medicine.
C57BL/6 mice were generated from a colony established in the
Washington University mouse facility. Mice constitutively deficient
in lipin 1 (fld mice), were compared to wild-type (+/+) littermate
control mice (Balb/cByJ strain).
Gene Expression Analyses
For quantitative PCR studies, first-strand cDNA was generated
by reverse transcription using total RNA. Real-time RT-PCR was
performed using the ABI PRISM 7500 sequence detection system
(Applied Biosystems, Foster City, CA) and the SYBR green kit.
Arbitrary units of target mRNA were corrected by measuring the
levels of 36B4 RNA.
Mammalian Cell Culture and Transient Transfection
Primary cultures of mouse hepatocytes were prepared as
described [12]. After a 2 h attachment period, hepatocytes were
infected with adenovirus to drive overexpression of proteins
defined below, then studied after 48 h of infection. Palmitate
oxidation rates were determined using 3H-palmitate as previously
described [2]. VLDL-TG secretion was measured using 3H-
glycerol after oleate stimulation (0.3 mM) as previously described
[12].
Transient Transfection and Luciferase Assays
HepG2 and HEK-293 cells were maintained in DMEM-10%
fetal calf serum. Transient transfections with luciferase reporter
constructs were performed by calcium-phosphate co-precipitation.
SV40-driven renilla luciferase expression construct was also
included in each well. For all vectors, promoterless reporters or
empty vector controls were included so that equal amounts of
DNA were transfected into each well. Luciferase activity was
quantified 48 h after transfection by using a luminometer and the
Stop & GloH dual luciferase kit (Promega). Assays were performed
in duplicate. To control for transfection efficiency, firefly luciferase
activity was corrected to renilla luciferase activity.
Co-immunoprecipitation and Western Blotting Analyses
In co-immunoprecipitation (co-IP) experiments, HepG2 cells
were lysed and incubations performed in NP40-containing lysis
buffer (20 mM Tris HCl, 100 mM NaCl, 0.5% NP40, 0.5 mM
EDTA, 0.5 mM PMSF, and protease inhibitor cocktail). Proteins
were immunoprecipitated using protein A-conjugated agarose
beads an antibody directed against HNF4a (Santa Cruz Biotech-
nology). Precipitated proteins were electrophoresed on acrylamide
gels. Western blotting analyses for IP studies and to demonstrate
overexpression of HA-tagged lipin 1 proteins were performed with
mouse monoclonal anti-HA antibody (Covance). Mouse anti actin
antibody was purchased from Sigma Chemical Co.
Chromatin Immunoprecipitation (ChIP) Assays
In experiments where ChIP was the endpoint, HepG2 cells
were cultured in 10 cm dishes and infected with Ad-GFP, Ad-
HNF4a, and/or Ad-lipin 1b. Approximately 48 h after infection,
proteins were cross-linked to chromatin by adding formaldehyde
to a final concentration of 1% and incubating for 15 minutes at
room temperature. Chromatin purification and ChIP assays were
performed by using a commercially available ChIP assay kit
(Upstate Biotechnology) according to the manufacturer’s instruc-
tions. PCR primers were designed to flank HNF4a response
elements and the sequence of these primers is available upon
request. For quantification, SYBR GREEN PCR was performed
using DNA obtained from ChIP.
DNA Constructs
Luciferase reporter driven by 2045 bp of the 59 flanking region
of the Lpin1 gene (22045.Lpin1.Luc) was the gift of Karen Reue
and the +2293.Lpin1.Luc, which contains 393 nucleotides of the 59
flanking sequence, the first Lpin1 exon (51 nucleotides), and
approximately 2,242 bp of the first intron of the mouse Lpin1 gene
into a promoterless luciferase reporter vector (+2293-Lpin1.luc),
has been recently described [13]. Ppara.Luc and Acadm.TKLuc
were the gift of Bart Staels and Daniel Kelly, respectively, and
have been reported and characterized previously [14,15]. The
homologous promoter-firefly luciferase reporter construct driven
by the entire intergenic region between the Apoc3 and Apoa4 genes
(Apoc3/Apoa4.Luc) has been described [16,17] and was the
generous gift of V. Giguerre. Apoc3/Apoa4 promoter luciferase
reporter constructs containing mutations in HNF4a response
elements were derived from the parent Apoc3/Apoa4.Luc construct
and were provided by B. Spiegelman [16]. The Apoc3 enhancer.3X.-
Luc heterologous reporter construct was driven by the thymidine
kinase minimal promoter and three copies of the human Apoc3
enhancer (59-GATCTCCCAGGGCGCTGGGCAAAGGT-
CACCTGCTGACCAGTGGAGATGAG-39; nuclear receptor
response element is underlined). The UAS-TKLuc has also been
previously described [10]. The SV40-driven renilla luciferase
DNA construct was obtained from Promega.
The 924 amino acid form of mouse lipin 1 (lipin 1b) fused to an
N-terminal triple HA tag was overexpressed using a pCDNA3.1
vector [10]. Expression constructs driving expression of lipin 1b
protein with a site-directed mutation changing isoleucine 726 and
leucine 727 to phenylalanine (LXXFF) were derived from the lipin
1b construct [4,10]. The HNF4a (pMT-HNF4a), PGC-1a, PGC-
1a-mL2 (LXXLL to LXXFF), and PGC-1b expression constructs
have also been described [18,19]. The Gal4-HNF4a expression
construct has also been described [20].
Adenoviral constructs to drive expression of HA-tagged lipin-
1b and/or GFP [4,10], Ad-HNF4a [16], and mutant lipin 1b
(LXXFF) [2] have been previously described. Adenoviral
transductions were carried out by incubating hepatocytes with
adenoviruses in a 5% FBS/DMEM media overnight in 24-well
plates (0.5 ml/well) or 6-well plates (2 ml/well) at an M.O.I. of
8. Experiments were carried out 40–48 h after adenoviral
transduction.
siRNA Studies
A human HNF4a-specific siRNA (siHNF4a) was obtained from
Sigma. Scramble control siRNA was synthesized using a SilencerH
Select siRNA kit (Ambion) as described [21]. The control siRNA
Lipin 1 and HNF4
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and siHNF4a were transfected onto HepG2 cells using a
Lipofectamine-2000 reagent (Invitrogen). At 14 hr after siRNA
transfection, the cells were infected with Ad-GFP or Ad-PGC-1a
and cultured for additional 34 hr and thereafter they were
harvested for RNA isolation or subjected to assays measuring
rates of palmitate oxidation as described above.
Figure 1. Lipin 1 is a target of HNF4a in HepG2 cells. [A] The schematic depicts luciferase reporter constructs driven by 2045 bp of 59 flanking
sequence or 2293 bp 39 from the transcriptional start site of the Lpin1 gene. Graphs depict results of luciferase assays using lysates from HepG2 cells
transfected with Lpin1.Luc reporter constructs and cotransfected with PGC-1a or PGC-1b expression constructs as indicated. The vector values are
normalized ( = 1.0). The results are the mean of 3 independent experiments done in triplicate. *p,0.05 versus pCDNA control. [B and C] Graphs
depict results of luciferase assays using lysates from HepG2 cells transfected with +2293.Lpin1.Luc reporter construct and cotransfected expression
constructs expressing WT or mL2 PGC-1a. The results are the mean of 3 independent experiments done in triplicate. *p,0.05 versus pCDNA control.
**p,0.05 versus pCDNA control and HNF4a or PGC-1a overexpression alone. [D] The images depict the results of chromatin immunoprecipitation
studies using chromatin from mouse hepatocytes infected with adenovirus to overexpress HNF4a. Crosslinked proteins were IP’ed with HNF4a
antibody or IgG controls. ‘‘Input’’ represents 0.2% of the total chromatin used in the IP reactions. PCR primers were designed to amplify two regions
of the Lpin1 gene promoter containing NRREs or exon 7 (negative control). [E] Inset images depict results of western blotting analyses for the HNF4a
and b-actin in HepG2 cells infected with adenovirus to overexpress PGC-1a or GFP (control) and transfected with siRNA to knockdown HNF4a or
scramble control siRNA. Graphs depict the expression of HNF4a or lipin 1 mRNA in HepG2 cells infected with adenovirus to overexpress PGC-1a or
GFP (control) and transfected with siRNA to knockdown HNF4a or scramble control siRNA (n = 6). *p,0.05 versus scramble control infected with the
same adenovirus. **p,0.05 versus all other groups.
doi:10.1371/journal.pone.0051320.g001
Figure 2. Lipin 1 enhances HNF4a-mediated increases in fatty acid oxidation. [A] The images depict the results of co-immunoprecipitation
studies using lysates from HepG2 cells infected with adenovirus driving expression of lipin 1b or lipin 1(LXXFF). HNF4a-containing complexes were
immunoprecipitated with an antibody directed against HNF4a or IgG control. Immunoprecipitated proteins were then subjected to immunoblotting
with antibody directed against the HA tag of overexpressed lipin 1. Input represents 5% of the total protein used in immunoprecipitation reactions.
[B] Graphs depict results of luciferase assays using lysates from HepG2 cells transfected with Acadm.TKLuc or Ppara.Luc and cotransfected with lipin 1
and/or HNF4a expression constructs as indicated. The results are the mean of 3 independent experiments done in triplicate. *p,0.05 versus pCDNA
control. **p,0.05 versus pcDNA or lipin 1 alone. ***p,0.05 versus all other groups. [C and D] Primary hepatocytes were isolated from 6 week old
C57BL/6 mice and infected with adenovirus driving expression of GFP or HNF4a in the presence or absence of overexpressed lipin 1b (wild-type or
LXXFF). The graphs depict [C] the expression of Ppara and Acadm (n = 5) or [D] mean rates of palmitate oxidation (mean of 3 independent
experiments done in triplicate) or *p,0.05 versus GFP control. **p,0.05 versus HNF4a overexpression alone. ***p,0.05 versus all other groups.
doi:10.1371/journal.pone.0051320.g002
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Statistical Analyses
Statistical comparisons were made using analysis of variance
(ANOVA) coupled to Scheffe’s test. All data are presented as
means 6 SEM, with a statistically significant difference defined as
a P value ,0.05.
Results
PGC-1a Induces Lipin 1 Expression through HNF4a in
HepG2 Cells
We have previously demonstrated that PGC-1a is an important
regulator of lipin 1 gene expression in liver [10], but the
transcription factor partners of PGC-1a that mediate this effect
remain unclear. To further dissect the transcriptional mechanisms
at play, we transfected HepG2 cells with expression constructs for
PGC-1a or PGC-1b and Lpin1 promoter-luciferase reporter
constructs. The PGC-1a responsive region was not contained in
the 2 kb 59 flanking sequence (22045.Lpin1.Luc) that is sufficient
to confer responsiveness to several other transcription factors
[22,23,24,25]. However, PGC-1a overexpression activated a
promoter driven by 393 nucleotides of the 59 flanking sequence,
the first Lpin1 exon (53 nucleotides), and 2,240 bp of the first
intron of the mouse lipin 1 gene (+2293-Lpin1.luc). This suggests
that the PGC-1a-responsive element in HepG2 cells is contained
in the first intron of the Lpin1 gene (Figure 1A). Interestingly,
PGC-1a overexpression did not affect Lpin1 promoter activity. To
begin to narrow the transcription factor partners of lipin 1 that
might be mediating this response, we overexpressed PGC-1a with
a site directed mutations in a leucine-rich (LXXLL to LXXFF)
motif that mediates interactions with nuclear receptor partners.
Mutation of the L2 domain of PGC-1a [26] was sufficient to
completely block the activation of Lpin1 promoter activity
(Figure 1B). These data indicate that the ability of PGC-1a to
induce lipin 1 expression depended upon a transcription factor
partner, likely a nuclear receptor, which interacted with the L2
domain.
Based on these results, we hypothesized that HNF4a might be
involved in this response since HNF4a requires the L2 motif of
PGC-1a to interact with that coactivator [27] and interacts only
weakly with PGC-1b [28]. Transfection of an expression construct
for HNF4a led to a 2-fold increase in Lpin1 promoter activity and
this was additively enhanced by cotransfection of PGC-1a
(Figure 1C). Chromatin immunoprecipitation studies confirmed
that HNF4a was interacting with chromatin at two previously-
identified [13] nuclear receptor response elements in the first
intron of the Lpin1 gene (Figure 1D), which is consistent with the
promoter mapping studies. Finally, knockdown of HNF4a protein
content by using siRNA led to diminished expression of Lpin1 in
HepG2 cells and abolished the induction in Lpin1 expression
caused by PGC-1a overexpression (Figure 1E).
Lipin 1 Enhances the Effects of HNF4a on Fatty Acid
Oxidation
We have previously demonstrated a direct protein-protein
interaction between HNF4a and lipin 1 in GST pull-down assays
[10]. To confirm the interaction between HNF4a and lipin 1,
HNF4a was immunoprecipitated from isolated hepatocytes
overexpressing lipin 1 protein that was either wild-type or
harboring a mutation in the LXXIL domain of lipin 1 that
mediates its interaction with PPARa [10]. Lipin 1 was found to be
immuno-coprecipitated with HNF4a and the interaction required
the LXXIL motif (Figure 2A). We next evaluated the functional
Figure 3. Lipin 1 deficiency impairs the ability of HNF4a to induce fatty acid oxidation. [A] Western blots inset above show the expression
of HNF4a in hepatocytes from WT and fld mice infected with adenovirus to overexpress HNF4a (or GFP control). Graphs depict the expression of the
indicated genes in hepatocytes from WT or fld hepatocytes infected with adenovirus to overexpress HNF4a or GFP (control) (n = 6). *p,0.05 versus
GFP. **p,0.05 versus GFP control and WT cells expressing HNF4a. [B] The graphs depicts rates of palmitate oxidation in the experiment described in
[A]. *p,0.05 versus WT GFP. **p,0.05 versus WT GFP and WT HNF4a.
doi:10.1371/journal.pone.0051320.g003
Lipin 1 and HNF4
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implications of this interaction. Lipin 1 significantly enhanced
HNF4a-mediated activation of the human PPARa gene promot-
er-luciferase reporter and multimerized HNF4a-responsive Acadm-
TKLuc reporter construct (Figure 2B), suggesting that lipin 1 was
acting in a feed forward manner to enhance HNF4a activity. Lipin
1 overexpression augmented the effects of HNF4a on the
expression of Ppara and Acadm genes (Figure 2C) and rates of fat
catabolism (Figure 2D) in hepatocytes in an LXXIL-dependent
manner.
We also took a lipin 1 loss of function approach to evaluate the
interaction between lipin 1 and HNF4a. Overexpression of similar
amounts of HNF4a in hepatocytes from fld mice, which lack lipin
1, was less effective at inducing the expression of genes encoding
PPARa and fatty acid oxidation enzymes (Cpt1a and Acadm)
(Figure 3A). The increase in rates of fatty acid oxidation induced
by HNF4a overexpression was blunted in fld hepatocytes
compared to WT controls (Figure 3B). Basal rates of palmitate
oxidation were also diminished in fld hepatocytes compared to WT
controls (Figure 3B). Collectively, these data indicate that lipin 1
enhances the stimulatory effects of HNF4a on fatty acid oxidation.
Lipin 1 Suppresses the Expression of Apoproteins that
are Induced by HNF4a
HNF4a is known to stimulate the expression of various genes
involved in VLDL metabolism [29], whereas we have shown that
lipin 1 suppresses the expression of these genes [2]. Lipin 1
overexpression suppressed the ability of HNF4a to induce the
expression of Apoa4 and Apoc3 in an LXXIL motif-dependent
manner (Figure 4A). HNF4a overexpression was also more potent
at inducing the expression of Apoa4 and Apoc3 in fld hepatocytes
compared to WT controls (Figure 4B). We also assessed rates of
TG synthesis and secretion by isolated hepatocytes from WT and
fld mice and found that, despite the role of lipin 1 in the TG
synthesis pathway, rates of TG synthesis were not affected by lipin
1 deficiency or HNF4a overexpression (Figure 4C). Consistent
with our previous work [12], rates of VLDL-TG synthesis were
significantly increased in hepatocytes from fld mice infected with
GFP adenovirus (Figure 4C). However, HNF4a-stimulated
secretion of newly synthesized VLDL-TG, which was strongly
enhanced by HNF4a overexpression, was not affected by loss of
lipin 1 (Figure 4C). This may be explained by the strong
stimulation of microsomal triglyceride transfer protein (Mttp)
expression by HNF4a, which is not affected by lipin 1 deficiency
Figure 4. Loss of lipin 1 enhances the effects of HNF4a on apoprotein gene expression. [A] Primary hepatocytes were isolated from 6
week old C57BL/6 mice and infected with adenovirus driving expression of GFP or HNF4a in the presence or absence of overexpressed lipin 1b (wild-
type or LXXFF). The graphs depict the expression of Apoa4 and Apoc3 (n = 5). *p,0.05 versus GFP. **p,0.05 versus GFP control and cells expressing
HNF4a alone. [B and C] Primary hepatocytes were isolated from 6 week old WT or fldmice and infected with adenovirus driving expression of GFP or
HNF4a. [B] The graph depicts the expression of Apoa4, Apoc3, or Mttp (n = 5) *p,0.05 versus WT GFP. **p,0.05 versus GFP groups and WT cells
expressing HNF4a. [C] Graphs depict rates of 3H-TAG synthesis and secretion in VLDL. *p,0.05 versus WT GFP. **p,0.05 versus GFP controls.
doi:10.1371/journal.pone.0051320.g004
Figure 5. Lipin 1 inhibits Apoc3/Apoa4 promoter activity in an HNF4a-dependent manner. [A] The schematic depicts the luciferase
reporter construct under control of the intergenic region between the genes encoding ApoC3 and ApoA4 (Apoc3/Apoa4.Luc). The relative positions
of two HNF4a response elements denoted as Apoc3 enhancer and Apoa4 enhancer are indicated. Graphs depict results of luciferase assays using
lysates from HepG2 cells transfected with Apoc3/Apoa4.Luc reporter constructs and cotransfected with lipin 1 and/or HNF4a expression constructs as
indicated. Apoc3/Apoa4.Luc constructs were either wild-type or contained mutations in the ApoC3 enhancer or ApoA4 enhancer HNF4a response
elements. The results are the mean of 3 independent experiments done in triplicate. *p,0.05 versus pCDNA control. **p,0.05 versus vector control
or lipin 1 cotransfection. [B] The schematic depicts the heterologous luciferase reporter construct driven by three copies of the Apoc3 enhancer
HNF4a response element. Graphs depict results of luciferase assays using lysates from HEK293 cells transfected with Apoc3 enhancer.3X.TKLuc and
cotransfected with empty vector (pcDNA and pMT), lipin 1, and/or HNF4a expression constructs as indicated. The results are the mean of 3
independent experiments done in triplicate. *p,0.05 versus pCDNA control. **p,0.05 versus vector control or lipin 1 cotransfection.
doi:10.1371/journal.pone.0051320.g005
Lipin 1 and HNF4
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(Figure 4B). These data suggest that lipin 1 modulates HNF4a
activity to selectively induce fatty acid catabolism whilst suppress-
ing expression of genes encoding apoproteins.
We sought to explore the molecular mechanism for the crosstalk
between lipin 1 and HNF4a using the Apoc3 and Apoa4 genes as a
model system. These two genes are located adjacent to one
another on human chromosome 11 and are oriented in opposing
directions so that the promoters and critical regulatory elements
that control transcription of both genes are located in a 6 kB
intergenic region [30]. HepG2 cells were transfected with a
luciferase promoter construct driven by the entire intergenic
region between the human Apoc3 and Apoa4 genes [17] in the
presence or absence of expression constructs for HNF4a and/or
lipin 1. As previously reported [16], HNF4a enhanced Apoc3/
Apoa4 promoter activity compared to empty vector control
(Figure 5A). Co-transfection of the lipin 1 expression vector
significantly repressed basal and HNF4a-induced Apoc3/Apoa4
promoter activity (Figure 5A).
A site-directed mutation that abrogates binding of HNF4a and
other nuclear receptors to a nuclear receptor response element
(NRRE) proximal to the Apoc3 gene (‘‘Apoc3 enhancer’’; [16])
prevented both the lipin 1-mediated suppression and the HNF4a-
induced activation of the Apoc3/Apoa4 promoter (Figure 5A). In
contrast, a mutation in another predicted HNF4aRE [16]
proximal to the Apoa4 gene (‘‘Apoa4 enhancer’’) did not influence
the effect of either lipin 1 or HNF4a (Figure 5A). The robust
HNF4a-mediated activation of a heterologous reporter containing
3 copies of the ‘‘Apoc3 enhancer’’ was also attenuated by
cotransfection of lipin 1b expression vector in HEK-293 cells
(Figure 5B).
Lipin 1 is not Associated with Chromatin in the Apoc3
Promoter
We sought to further dissect the transcriptional regulatory
mechanisms mediating the divergent effects of lipin 1 on HNF4a
activity. Consistent with the gene expression and promoter assays
above, chromatin immunoprecipitation (ChIP) analyses demon-
strated that HNF4a occupancy of the Apoc3 promoter was
diminished by lipin 1 overexpression, whereas HNF4a occupancy
of the Ppara promoter was significantly increased by lipin 1
(Figure 6A). However, ChIP analyses utilizing an antibody to the
HA epitope tag of lipin 1 did not detect a significant interaction
between lipin 1 and chromatin in the Apoc3 promoter (Figure 6A).
In contrast, significant cross-linking of lipin 1 to the Ppara
promoter was detected. To examine the effects of lipin 1 on
HNF4a intrinsic activity in a promoter-independent fashion, the
activity of a Gal4-HNF4a fusion construct on a multimerized
Gal4-response element-driven luciferase reporter (UAS-TKLuc)
was examined. Lipin 1 overexpression enhanced Gal4-HNF4a
activity by more than 3-fold in this mammalian two-hybrid system
(Figure 6B). We propose that the suppression of Apoc3/Apoa4
promoter activity is not mediated via an active repression
mechanism and that lipin 1 may influence HNF4a promoter
occupancy by directing it towards promoters of genes encoding
proteins that affect fatty acid oxidation.
Discussion
HNF4a is a nuclear receptor transcription factor that is a
critical regulator of hepatic gene expression. Previous work has
demonstrated important roles for HNF4a in regulating the
expression of enzymes involved in VLDL metabolism
[16,31,32,33], fatty acid oxidation [18], and a broad profile of
genes that define liver development [34]. In this work, we show
that the expression of Lpin1 is also under the control of HNF4a in
HepG2 cells and hepatocytes and that this occurs via a direct
transcriptional mechanism involving a promoter in the first intron
Figure 6. Lipin 1 influences HNF4a promoter occupancy. [A] The
image depicts the results of ChIP assays using chromatin from HepG2
cells infected with GFP, HNF4a and/or lipin 1b. Chromatin was
immunoprecipitated with antibodies directed against HNF4a, the HA
tag of lipin 1b or IgG control. Input represents 0.2% of the total
chromatin used in the IP reactions. PCR primers were designed to flank
the HNF4a response elements in the Apoc3 or Ppara gene promoters.
Control primers were designed to amplify the 36B4 gene. The graph
depicts results of real-time PCR (SYBR GREEN) to quantify immunopre-
cipitated chromatin. The results are the mean of 3 independent
experiments done in duplicate. *p,0.05 versus pCDNA control.
**p,0.05 versus HNF4a alone. [B] Graphs depict results of luciferase
assays using lysates from HepG2 cells transfected with UAS.TKLuc and
cotransfected with Gal4-HNF4a or Gal4-DNA binding domain (DBD)
control and/or lipin 1expression constructs as indicated. The results are
the mean of 3 independent experiments done in triplicate. *p,0.05
versus pCDNA control.
doi:10.1371/journal.pone.0051320.g006
Lipin 1 and HNF4
PLOS ONE | www.plosone.org 8 December 2012 | Volume 7 | Issue 12 | e51320
of the Lpin1 gene. There have been hints in previous studies using
‘omic’ approaches that lipin 1 may be a target gene of HNF4a.
Lpin1 was down-regulated by siRNA against HNF4a and
identified in HNF4a ChIP-seq experiments by Bolotin and
collegues [35]. In that work, the interaction of HNF4a was
generally localized to 39 to the transcriptional start site of the Lpin1
gene, which coincides with our findings using promoter luciferase
reporter constructs and targeted ChIP approaches. We have also
shown that PGC-1a is a critical regulator of lipin 1 expression
[10]. HNF4a is also an important partner of PGC-1a for
mediating many aspects of the hepatic fasting response; a
physiologic condition associated with increased lipin 1 expression
[10]. In cardiac myocytes, we have recently shown that PGC-1a
coactivates member of the ERR family through these same
response elements to induce lipin 1 expression [13]. This suggests
that the nuclear receptor partner coactivated by PGC-1a varies
depending upon the cell type and expression level of the partners.
HNF4a is enriched in hepatocytes, but few other tissues [31].
ERRa and ERRc expression levels were at or below the edge of
detection in HepG2 cells (unpublished observation), but these
nuclear receptors are well expressed in muscle cells [27,36].
Collectively, these data strongly support the idea that lipin 1 is a
direct HNF4a target gene in liver cells that is induced in
physiologic conditions wherein PGC-1a is activated to coactivate
HNF4a.
We have previously shown that lipin 1 and HNF4a physically
interact [10], but the physiologic consequences of the interaction
and the induction of lipin 1 by HNF4a was not clear. In this work,
we showed that increased lipin 1 availability affected HNF4a
activity in a pathway-specific manner, suggesting that the
activation of lipin 1 serves to feed forward and modulate HNF4a
activity. Lipin 1 enhanced HNF4a-mediated activation of fatty
acid oxidation while abrogating the ability of HNF4a to induce
Apoa4 and Apoc3 gene expression. In the nucleus, lipin 1 can
function as either a coactivator or corepressor depending upon the
context of its transcription factor partner. Lipin 1 is most likely a
molecular scaffold that recruits histone acetyltransferases or
deacetylases to enhance or repress transcription depending upon
the transcription factor partner [10,11]. However, since ChIP
analyses did not detect the presence of lipin 1 on the Apoc3
enhancer and Gal4-HNF4a activity, a measure of intrinsic activity
independent of promoter binding, was enhanced by lipin 1, lipin 1
is probably not inhibiting HNF4a activity by an active repression
mechanism. Rather, we surmise that lipin 1 may be mediating this
effect by binding to HNF4a and directing its binding to the
promoter of one gene versus another. Other coregulatory proteins
that act in a promoter-specific manner have been reported. For
example, in adipocytes, PGC-1a strongly coactivates PPARc on
the Ucp1 promoter, but does not enhance expression of Fabp4 [37],
which is also a robust and primary PPARc target gene [38].
Although it is still unclear how promoter selectivity by coregula-
tory proteins is mediated, it is possible that the presence of other
response elements and DNA-bound transcription factors on
certain promoters is required to influence occupancy.
In many ways, the present studies clarify several mechanistic
questions from our previous work. For example, although PPARa
is coactivated by lipin 1, PPARa deficiency did not affect the
transcriptional effects of lipin 1 in liver [10]. The present data
indicate that this observation can be explained by the HNF4a-
lipin 1 interaction. We also previously reported that Apoa4 is
markedly overexpressed in liver of fld mice [39], lipin 1
overexpression suppressed the expression of Apoc3 and Apoa4,
and the transcriptional activity of lipin 1 was required for this
repressive effect [2]. In this work, we provide a more detailed
mechanistic explanation for this observation using the Apoc3/Apoa4
gene cluster, which is well-characterized as an HNF4a target
[16,31,40,41,42,43]. However, it is unlikely that the modulation of
Apoc3/Apoa4 expression per se is sufficient to explain our previous
report that lipin 1inhibits hepatic VLDL-TG secretion [44,45,46].
HNF4a overexpression was equally efficacious at increasing
VLDL-TG secretion in WT and fld hepatocytes, likely because
of a strong induction of Mttp, which is known to be sufficient to
stimulate VLDL secretion. The identification of the gene targets
mediating this response will be the subject of future inquiry.
In conclusion, we demonstrate herein that the gene encoding
lipin 1 is direct target gene of HNF4a that feeds forward to
modulate HNF4a activity, seemingly in a promoter-specific
manner. Whereas lipin 1 promotes the expression of genes
encoding fatty acid oxidation enzymes in response to HNF4a
overexpression, lipin overexpression impedes the induction of
apolipoprotein gene expression by this nuclear receptor. These
data suggest that lipin 1 functions to promote the catabolic actions
of HNF4a, which fits with the induction of lipin 1 in liver of
starved mice when rates of fatty acid oxidation are high. These
findings also suggest that promoting expression of lipin 1 in liver
could help to clear liver fat by promoting its degradation in b-
oxidative pathways.
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